Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition.
Schmidt ENC, Evert BO, Pregler BEF, Melhem A, Hsieh MC, Raspe M, Strobel H, Roos J, Pietsch T, Schuss P, Fischer-Posovszky P, Westhoff MA, Hölzel M, Herrlinger U, Vatter H, Waha A, Schneider M, Potthoff AL.
Schmidt ENC, et al.
Mol Oncol. 2024 Dec 16. doi: 10.1002/1878-0261.13786. Online ahead of print.
Mol Oncol. 2024.
PMID: 39680504
Free article.